Loading clinical trials...
Loading clinical trials...
The project examines the hypothesis that monoclonal allergen-neutralizing antibodies can be recombinantly produced from B lymphocytes isolated from pollen allergic patients. Patient samples suitable f...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Mabylon AG
NCT07412990 · Grass Pollen Allergy
NCT04502966 · Allergic Rhinoconjunctivitis, Grass Pollen Allergy
NCT05560698 · Grass Pollen Allergy, Rhinoconjunctivitis
NCT04622917 · Rhinitis, Allergic, Seasonal, Hay Fever, and more
NCT04874714 · Allergic Rhinoconjunctivitis, Perennial Allergic Rhinitis, and more
Immunologie Zentrum Zürich
Zurich, Canton of Zurich
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions